Dexcom skyrockets on Street-beating Q4

February 14, 2020 By Sean Whooley

Dexcom (NSDQ:DXCM) shares took a big jump up today on fourth-quarter results that topped the consensus forecast with relative ease and improved upon losses from the company’s previous fourth quarter.

Shares of DXCM were up 13.8% at $286.96 per share in late-morning trading today.

The San Diego–based continuous glucose monitor maker posted profits of $92.7 million, or $1.00 per share, on sales of $462.8 million for the three months ended Dec. 31, 2019, making vast improvements from Q4 2018’s loss of -$179.7 million on Q4 2019 sales growth of 36.9%.

Adjusted to exclude one-time items, earnings per share were $1.15, 41¢ ahead of Wall Street, where analysts were looking for sales of $442.4 million.

“Dexcom sustained its revenue growth momentum in 2019, exceeding 40% growth for the second consecutive year and driving our first full year of GAAP profitability,” Dexcom chairman, president & CEO Kevin Sayer said in a news release. “We have taken significant steps to prepare the business for longterm growth and believe we are well-positioned as we enter 2020.”

Dexcom reaffirmed its prior sales guidance for fiscal 2020, setting it to range between $1.725 billion and $1.775 billion.

Contract manufacturers fuel medtech expansion in Costa Rica
Medical device manufacturing is flourishing in the Central American country, spurred by a host of incentives. This year is seeing a wave of expansions by medtech contract manufacturers in Costa Rica. Medtech OEMs have made the Central American company a manufacturing hub since the 1990s. Major companies operating there include Abbott, Bayer, Boston Scientific, Cardinal… […]
Purdue researchers develop biosensor for use during surgery
Surgeons may soon be able to identify critical regions in tissues and organs during surgery using a biosensor recently developed at Purdue University. The biosensor can be printed in 3D using an automated printing system and allows for simultaneous recording and imaging of tissues and organs during surgery, according to its creator, Chi Hwan Lee.… […]
Amcor adds heat seal coating for medtech packaging
Amcor has introduced a new heat seal coating for medical-grade DuPont Tyvek and paper packaging applications. The Buffalo Grove, Ill.-based company designed this next-generation coating technology to deliver enhanced performance features for healthcare applications. Amcor will produce the new coating, ACT2100, in multiple locations worldwide to offer customers the flexibility to receive supply from the… […]
Latest iCad 3D mammography AI gains CE mark
iCad (NSDQ:ICAD) today announced that the third version of its ProFound AI for digital breast tomosynthesis (DBT) has won CE mark approval. Compared with previous software versions, the latest generation of ProFound AI offers up to a 10% improvement in specificity performance while maintaining a high sensitivity level and approximately 40% faster processing on the… […]
Device could reduce chemotherapy-induced pain
Researchers in Singapore have partnered with Paxman Coolers (U.K.) to develop a device to prevent or reduce numbness and pain caused by chemotherapy. Chemotherapy-induced peripheral neuropathy (CIPN) is a severe side-effect of chemotherapy drugs called taxanes, which are used to treat common cancers such as breast, lung, ovarian and stomach cancer. CIPN affects about 1.4… […]
What medtech’s top executives learned from their dads
For better or worse, parents including dads play a major role in who we become. With Father’s Day approaching in the U.S., Medical Design & Outsourcing and MassDevice reached out to some of medtech’s top executives to ask what they learned from their dads. Here’s what they said: “My father built a business in the… […]
FDA issues docs on medtech remanufacturing, servicing
The FDA has issued two documents to help distinguish between remanufacturing and servicing of medical devices. One is a draft guidance written to clarify the activities that likely constitute the remanufacturing of a device. The other is a discussion paper on cybersecurity and medtech servicing. The guidance also describes the FDA’s current position on remanufacturing,… […]
HelixBind wins $3M grant for sepsis test
HelixBind announced today it has landed a $3 million federal grant to help develop a test to diagnose bloodstream infections associated with sepsis. The FDA granted Breakthrough Device Designation to the RaPID/BSI test and platform in 2020. Boxborough, Mass.-based HelixBind’s RaPID platform can provide definitive identification and characterization of infections directly from a blood draw… […]
Supreme Court upholds Affordable Care Act again
The U.S. Supreme Court has turned back a third Republican challenge to the Affordable Care Act (ACA), this time by a 7-2 vote. The latest challenge to the law popularly known as Obamacare came from Texas and other states, backed by the administration of former President Donald Trump. The justices ruled that the challengers lacked… […]
New monitor could diagnose pregnancy complications
Researchers at the National Institutes of Health (NIH) have developed a prototype device that could potentially diagnose pregnancy complications by monitoring the oxygen level of the placenta. The device sends near-infrared light through the abdomen to measure oxygen levels in the arterial and venous network in the placenta. The method was used to study the… […]
Dabir Surfaces forges deal with Vizient
Dabir Surfaces (Harwood Heights, Ill.) recently announced that it has landed a contract with group purchasing firm Vizient. Dabir also announced a deal with Premier this month. The contract with Vizient, effective April 1, 2021, involves both OR products and patient care products. Dabir will provide powered overlay surfaces for patients at risk of developing pressure… […]